Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-PROSE: Furosemide vs Saline for Kidney Protection in Acute Heart Failure
NCT07550790Recruiting
- Start
- Jul 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of furosemide in contrast-induced acute kidney injury (CI-AKI) (2 arms). Primary endpoint: Incidence of contrast-associated acute kidney injury at 48 hours. Started Jul 2026; status: recruiting.
02
Drugs
furosemide
03
Conditions
contrast-induced acute kidney injury (CI-AKI)
Beyond the preview
Go deeper on NCT07550790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07550790.